Literature DB >> 18645283

Collecting duct renal cell carcinoma: two different clinical stages, two different clinical outcomes.

L G Vázquez-Lavista1, N Uribe-Uribe, F Gabilondo-Navarro.   

Abstract

Collecting duct carcinoma (CDC) of Bellini is a rare variant of renal cell carcinoma. It tends to be more aggressive when locally advanced or when having distant spread on diagnosis. The only favorable prognosis factor is low-stage, low-grade, with disease-free survival reported up to 5 years. We reviewed our renal cell carcinoma database and found 2 cases of CDC, namely 1 young female with locally advanced disease with supraclavicular metastasis and a dismissal prognosis, and 1 male with localized disease with 10-year disease-free survival. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18645283     DOI: 10.1159/000137652

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  6 in total

1.  Bellini's duct carcinoma: A report of two cases and a review of the literature.

Authors:  Yifan Li; L U Jin; Jiaju Liu; Duqun Chen; Zhengming Su; Liqun Zhou; Bentao Shi; Yongqing Lai
Journal:  Oncol Lett       Date:  2016-04-18       Impact factor: 2.967

2.  A case report of collecting duct carcinoma of the kidney coexistent with giant adrenal myelolipoma.

Authors:  Bingkun Li; Qiang Ding
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

3.  Effect of collecting duct histology on renal cell cancer outcome.

Authors:  Jonathan L Wright; Michael C Risk; James Hotaling; Daniel W Lin
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

4.  Management of renal collecting duct carcinoma: a systematic review and the McMaster experience.

Authors:  S Dason; C Allard; A Sheridan-Jonah; J Gill; H Jamshaid; T Aziz; B Kajal; A Kapoor
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

5.  Impact of Treatment Modalities on Prognosis in Patients With Renal Collecting Duct Carcinoma: A Population-Based Study.

Authors:  Xiaoyuan Qian; Jinzhou Xu; Chenqian Liu; Mingliang Zhong; Senyuan Hong; Can Qian; Jianning Zhu; Jiaqiao Zhang; Shaogang Wang
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

Review 6.  Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease.

Authors:  Cristina Suarez; David Marmolejo; Augusto Valdivia; Rafael Morales-Barrera; Macarena Gonzalez; Joaquin Mateo; Maria Eugenia Semidey; David Lorente; Enrique Trilla; Joan Carles
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.